Sign In
Buy CPRX
$31.49
+0 (+0%)
At Close: Jul 31, 2026
Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Surpass Estimates
09:55pm, Monday, 10'th Aug 2020
Catalyst (CPRX) delivered earnings and revenue surprises of 12.50% and 2.20%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Catalyst Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
08:15pm, Monday, 10'th Aug 2020
\- Firdapse® Second Quarter Net Revenues of $29.6 Million \- Health Canada Approves Marketing Authorization for Firdapse® for Treating LEMS Patients\- MuSK-MG Phase 3 Trial did not Achieve Statisti
It’s a Terrible Idea to Retire With ONLY Your OAS and CPP Pension
07:00pm, Monday, 10'th Aug 2020
Countless retirees are regretting not building enough of a nest egg after discovering that the OAS and CPP are insufficient. The Toronto-Dominion Bank stock, which could provide lifetime income, can b
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
5 Midcap Magic Formula Stocks For Total Return
10:34pm, Friday, 07'th Aug 2020
Considering all that has happened in 2020, I thought it might be interesting to present a screen of stocks based on Joel Greenblatt’s magic formula.
Lucinda wonders how to organize investments after the coronavirus accelerated her decision to sell her house
10:00pm, Friday, 07'th Aug 2020
Her existing portfolio is a mixture of ETFs and mutual funds with an asset mix of 48-per-cent stocks and 52-per-cent cash and fixed income
Earnings Preview: Catalyst Pharmaceuticals
03:11pm, Friday, 07'th Aug 2020
Catalyst Pharmaceuticals (NASDAQ: CPRX) announces its next round of earnings this Monday, August 10. Here is Benzinga's everything-that-matters guide for this Monday's Q2 earnings announcement.Earning
Retirees: Boost Your CPP Payments the Easy Way
12:33pm, Thursday, 06'th Aug 2020
Here's how retirees can support CPP payouts by investing in quality dividend companies such as Pembina Pipeline (TSX:PPL).
Catalyst Pharmaceuticals’ Firdapse® (amifampridine phosphate) Receives Marketing Approval in Canada for Patients with LEMS
12:03pm, Thursday, 06'th Aug 2020
CORAL GABLES, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing i
CPP Pension Users: 3 Shrewd Ways to Avoid the 15% OAS Clawback
12:00pm, Wednesday, 05'th Aug 2020
You can follow three clever ways of CPP pensioners to avoid the 15% OAS clawback. Consider investing in the Bank of Montreal stock too, which is the top-of-mind investment choice of retirees.
CPP Pension: How to Increase Your Monthly Income
11:48am, Tuesday, 04'th Aug 2020
With the maximum monthly benefit from CPP currently at $1,175.83, Canadians are searching for ways to boost their monthly income.
Immunic Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:IMUX)
10:33am, Tuesday, 04'th Aug 2020
Immunic announced positive top line data for IMU-838. Catalyst Pharma gets stung in FDA lawsuit.
Here's How Much Investing $1,000 In Catalyst Pharmaceuticals In 2010 Would Be Worth Today
12:00am, Tuesday, 04'th Aug 2020
Investors who owned stocks in the 2010s generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return for the decade was 250.5%. But there’s...
Catalyst Pharmaceuticals Announces Change to a Virtual Meeting Format for the 2020 Annual Meeting of Stockholders
08:15pm, Monday, 03'rd Aug 2020
CORAL GABLES, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing i
CORAL GABLES, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing i
